Kimo Bachiashvili

416 total citations
18 papers, 54 citations indexed

About

Kimo Bachiashvili is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Kimo Bachiashvili has authored 18 papers receiving a total of 54 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 6 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Kimo Bachiashvili's work include Acute Myeloid Leukemia Research (13 papers), Acute Lymphoblastic Leukemia research (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Kimo Bachiashvili is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Acute Lymphoblastic Leukemia research (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Kimo Bachiashvili collaborates with scholars based in United States, Tanzania and Canada. Kimo Bachiashvili's co-authors include Omer Jamy, Sravanti Rangaraju, Pankit Vachhani, Ravi Bhatia, Mark D. Minden, Sankalp Arora, Gautam Borthakur, Sameem Abedin, Antonio Di Stasi and V. V. Moroz and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Kimo Bachiashvili

12 papers receiving 54 citations

Peers

Kimo Bachiashvili
Valentine Richez France
Lisa Gu United States
Fabrizio Ciambelli Italy
Gudrun Goehring Germany
Lindsey Lyle United States
Frédéric Millot France
Sophie Dimicoli‐Salazar France
Eva A. Coenen Netherlands
Josip Batinić Croatia
I Hassan Pakistan
Valentine Richez France
Kimo Bachiashvili
Citations per year, relative to Kimo Bachiashvili Kimo Bachiashvili (= 1×) peers Valentine Richez

Countries citing papers authored by Kimo Bachiashvili

Since Specialization
Citations

This map shows the geographic impact of Kimo Bachiashvili's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimo Bachiashvili with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimo Bachiashvili more than expected).

Fields of papers citing papers by Kimo Bachiashvili

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimo Bachiashvili. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimo Bachiashvili. The network helps show where Kimo Bachiashvili may publish in the future.

Co-authorship network of co-authors of Kimo Bachiashvili

This figure shows the co-authorship network connecting the top 25 collaborators of Kimo Bachiashvili. A scholar is included among the top collaborators of Kimo Bachiashvili based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimo Bachiashvili. Kimo Bachiashvili is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Vachhani, Pankit, Kimo Bachiashvili, Sravanti Rangaraju, et al.. (2025). Real-World Evidence of Treatment-Free Remission Strategies and Outcomes in Chronic Myeloid Leukemia. Cancers. 17(13). 2148–2148.
3.
Al‐Kadhimi, Zaid, Kimo Bachiashvili, Sravanti Rangaraju, et al.. (2024). Idarubicin and cytarabine with and without midostaurin for FLT3-mutated acute myeloid leukemia. Leukemia & lymphoma. 65(11). 1737–1739. 1 indexed citations
4.
5.
Al‐Kadhimi, Zaid, Kimo Bachiashvili, Sravanti Rangaraju, et al.. (2024). Addition of single dose gemtuzumab ozogamicin to intensive induction chemotherapy in core-binding factor acute myeloid leukemia. Leukemia Research. 139. 107467–107467. 2 indexed citations
6.
Watts, Justin M., Mark D. Minden, Kimo Bachiashvili, et al.. (2024). Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasms. Therapeutic Advances in Hematology. 15. 1574193136–1574193136. 18 indexed citations
7.
Al‐Kadhimi, Zaid, Kimo Bachiashvili, Sravanti Rangaraju, et al.. (2023). Addition of Single Dose Gemtuzumab Ozogamicin to Intensive Induction Chemotherapy in Core-Binding Factor Acute Myeloid Leukemia. Blood. 142(Supplement 1). 5848–5848.
8.
Bachiashvili, Kimo, Ravi Bhatia, Omer Jamy, et al.. (2023). Utility of end of induction bone marrow biopsy and survival outcomes in acute promyelocytic leukemia treated with fixed-dose induction regimen. Leukemia & lymphoma. 64(10). 1673–1680.
9.
10.
Wolfson, Julie, Pankit Vachhani, Sravanti Rangaraju, et al.. (2022). Safe and Effective Use of Imatinib to Treat Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia During Pregnancy. Journal of Adolescent and Young Adult Oncology. 11(6). 617–620. 1 indexed citations
11.
Arora, Sankalp, Kimo Bachiashvili, Ravi Bhatia, et al.. (2022). Tumor lysis syndrome and infectious complications during treatment with venetoclax combined with azacitidine or decitabine in patients with acute myeloid leukemia. Leukemia Research. 117. 106844–106844. 10 indexed citations
12.
Arora, Sankalp, Sejong Bae, Kimo Bachiashvili, et al.. (2022). Dismal survival outcomes of patients with acute myeloid leukemia after failure of venetoclax with hypomethylating agents. Leukemia & lymphoma. 63(13). 3245–3248. 5 indexed citations
13.
Vachhani, Pankit, Guru Subramanian Guru Murthy, Omer Jamy, et al.. (2022). A phase 1 study of NTX-301, an oral DNMT1 inhibitor, in patients with MDS and AML (trial in progress).. Journal of Clinical Oncology. 40(16_suppl). TPS7077–TPS7077. 3 indexed citations
14.
Garcia‐Manero, Guillermo, Kimo Bachiashvili, Harshad Amin, et al.. (2022). ASTX727-03: Phase 1 Study Evaluating Oral Decitabine/Cedazuridine (ASTX727) Low-Dose (LD) in Lower-Risk Myelodysplastic Syndromes (LR-MDS) Patients. Blood. 140(Supplement 1). 1112–1114. 4 indexed citations
15.
Bachiashvili, Kimo, Liton Francisco, Yanjun Chen, et al.. (2021). Peripheral blood parameter abnormalities precede therapy‐related myeloid neoplasms after autologous transplantation for lymphoma. Cancer. 128(7). 1392–1401. 2 indexed citations
16.
Aluri, Srinivas, Kimo Bachiashvili, Tushar D. Bhagat, et al.. (2019). Clinical ALK5 Inhibitor, Vactosertib, Reverses TGFβ-1 Stimulated Smad-2 Driven Ineffective Hematopoiesis in MDS. Blood. 134(Supplement_1). 2990–2990. 4 indexed citations
17.
18.
Pendurti, Gopichand, Aditi P. Singh, Urvi A. Shah, et al.. (2017). Targeting the anterior superior iliac spine yields significantly longer bone marrow cores. Journal of Clinical Pathology. 71(2). 172–173. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valentine Richez Breakdown of academic impact, for papers by Lisa Gu Breakdown of academic impact, for papers by Fabrizio Ciambelli Breakdown of academic impact, for papers by Gudrun Goehring Breakdown of academic impact, for papers by Lindsey Lyle Breakdown of academic impact, for papers by Frédéric Millot Breakdown of academic impact, for papers by Sophie Dimicoli‐Salazar Breakdown of academic impact, for papers by Eva A. Coenen Breakdown of academic impact, for papers by Josip Batinić Breakdown of academic impact, for papers by I Hassan
Rankless by CCL
2026